University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Douglas Bauer, M.D.



General Internal Medicine
1545 Divisadero St., First and Second Floors
San Francisco, CA 94115
New Patient Appointments:
(844) 727-8273 (PCP-UCSF)
Office: (415) 353–7900
Fax, First Floor: (415) 353–2583
Fax, Second Floor: (415) 353–2640

Hours: Monday to Friday
8:30 a.m. – 5 p.m.

More about Douglas Bauer


University of Colorado 1982


UCSF, Internal Medicine 1985

Selected Research and Publications

  1. Kalogeropoulos AP, Georgiopoulou VV, Murphy RA, Newman AB, Bauer DC, Harris TB, Yang Z, Applegate WB, Kritchevsky SB. Dietary Sodium Content, Mortality, and Risk for Cardiovascular Events in Older Adults: The Health, Aging, and Body Composition (Health ABC) Study. JAMA Intern Med. 2015 Mar 1; 175(3):410-9.
  2. Lo-Ciganic WH, Perera S, Gray SL, Boudreau RM, Zgibor JC, Strotmeyer ES, Donohue JM, Bunker CH, Newman AB, Simonsick EM, Bauer DC, Satterfield S, Caserotti P, Harris T, Shorr RI, Hanlon JT. Statin use and decline in gait speed in community-dwelling older adults. J Am Geriatr Soc. 2015 Jan; 63(1):124-9.
  3. Ensrud KE, Blackwell TL, Cauley JA, Dam TT, Cawthon PM, Schousboe JT, Barrett-Connor E, Stone KL, Bauer DC, Shikany JM, Mackey DC. Objective measures of activity level and mortality in older men. J Am Geriatr Soc. 2014 Nov; 62(11):2079-87.
  4. Marcum ZA, Hanlon JT, Strotmeyer ES, Newman AB, Shorr RI, Simonsick EM, Bauer DC, Boudreau R, Donohue JM, Perera S. Gastroprotective Agent Underuse in High-Risk Older Daily Nonsteroidal Anti-Inflammatory Drug Users over Time. J Am Geriatr Soc. 2014 Oct; 62(10):1923-7.
  5. Hue TF, Cummings SR, Cauley JA, Bauer DC, Ensrud KE, Barrett-Connor E, Black DM. Effect of bisphosphonate use on risk of postmenopausal breast cancer: results from the randomized clinical trials of alendronate and zoledronic Acid. JAMA Intern Med. 2014 Oct 1; 174(10):1550-7.
  6. McNabb B, Vittinghoff E, Eastell R, Schwartz AV, Bauer DC, Ensrud K, Barrett-Connor E, Black DM. A Model of BMD Changes After Alendronate Discontinuation to Guide Postalendronate BMD Monitoring. J Clin Endocrinol Metab. 2014 Nov; 99(11):4094-100.
  7. Krähenmann-Müller S, Virgini VS, Blum MR, da Costa BR, Collet TH, Martin Y, Cornuz J, Zimmerli L, Gaspoz JM, Bauer DC, Kerr EA, Aujesky D, Rodondi N. Patient and physician gender concordance in preventive care in university primary care settings. Prev Med. 2014 Oct; 67:242-7.
  8. Wirth CD, Blum MR, da Costa BR, Baumgartner C, Collet TH, Medici M, Peeters RP, Aujesky D, Bauer DC, Rodondi N. Subclinical Thyroid Dysfunction and the Risk for Fractures: A Systematic Review and Meta-analysis. Ann Intern Med. 2014 Aug 5; 161(3):189-99.
  9. Lee DS, Markwardt S, Goeres L, Lee CG, Eckstrom E, Williams C, Fu R, Orwoll E, Cawthon PM, Stefanick ML, Mackey D, Bauer DC, Nielson CM. Statins and physical activity in older men: the osteoporotic fractures in men study. JAMA Intern Med. 2014 Aug 1; 174(8):1263-70.
  10. Weiler S, Gemperli A, Collet TH, Bauer DC, Zimmerli L, Cornuz J, Battegay E, Gaspoz JM, Kerr EA, Aujesky D, Rodondi N. Clinically relevant quality measures for risk factor control in primary care: a retrospective cohort study. BMC Health Serv Res. 2014; 14(1):306.
  11. Bauer DC, Schwartz A, Palermo L, Cauley J, Hochberg M, Santora A, Cummings SR, Black DM. Fracture Prediction After Discontinuation of 4 to 5 Years of Alendronate Therapy: The FLEX Study. JAMA Intern Med. 2014 Jul 1; 174(7):1126-34.
  12. Stott DJ, Bauer DC, Ford I, Kearney P, Gussekloo J, Quinn TJ, Rodondi N, Smit J, Westerdorp R. The Dilemma of Treating Subclinical Hypothyroidism: Risk that Current Guidelines Do More Harm than Good. Eur Thyroid J. 2014 Jun; 3(2):137-8.
  13. Collet TH, Bauer DC, Cappola AR, Asvold BO, Weiler S, Vittinghoff E, Gussekloo J, Bremner A, den Elzen WP, Maciel RM, Vanderpump MP, Cornuz J, Dörr M, Wallaschofski H, Newman AB, Sgarbi JA, Razvi S, Völzke H, Walsh JP, Aujesky D, Rodondi N. Thyroid antibody status, subclinical hypothyroidism, and the risk of coronary heart disease: an individual participant data analysis. J Clin Endocrinol Metab. 2014 Sep; 99(9):3353-62.
  14. Napoli N, Strotmeyer ES, Ensrud KE, Sellmeyer DE, Bauer DC, Hoffman AR, Dam TT, Barrett-Connor E, Palermo L, Orwoll ES, Cummings SR, Black DM, Schwartz AV. Fracture risk in diabetic elderly men: the MrOS study. Diabetologia. 2014 Oct; 57(10):2057-65.
  15. Streit S, da Costa BR, Bauer DC, Collet TH, Weiler S, Zimmerli L, Frey P, Cornuz J, Gaspoz JM, Battegay E, Kerr E, Aujesky D, Rodondi N. Multimorbidity and quality of preventive care in swiss university primary care cohorts. PLoS One. 2014; 9(4):e96142.
  16. Gencer B, Butler J, Bauer DC, Auer R, Kalogeropoulos A, Marques-Vidal P, Applegate WB, Satterfield S, Harris T, Newman A, Vittinghoff E, Rodondi N. Association of electrocardiogram abnormalities and incident heart failure events. Am Heart J. 2014 Jun; 167(6):869-875.e3.
  17. Szulc P, Blackwell T, Schousboe JT, Bauer DC, Cawthon P, Lane NE, Cummings SR, Orwoll ES, Black DM, Ensrud KE. High hip fracture risk in men with severe aortic calcification: MrOS study. J Bone Miner Res. 2014 Apr; 29(4):968-75.
  18. Bajaj A, Stone KL, Peters K, Parimi N, Barrett-Connor E, Bauer D, Cawthon PM, Ensrud KE, Hoffman AR, Orwoll E, Schernhammer ES. Circulating Vitamin D, Supplement Use, and Cardiovascular Disease Risk: The MrOS Sleep Study. J Clin Endocrinol Metab. 2014 Sep; 99(9):3256-62.
  19. Bauer DC. The calcium supplement controversy: now what? J Bone Miner Res. 2014 Mar; 29(3):531-3.
  20. Bauer DC. Vertebral augmentation for symptomatic compression fractures is supported by randomized clinical trials-reply. JAMA Intern Med. 2014 Feb 1; 174(2):307-8.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.